Parkview Health Research Repository
Not a member yet
    774 research outputs found

    College students in distress: Can social media be a source of social support?

    Get PDF
    Objective: Our goal was to examine undergraduates’ social support sources, including social media (SM) sources and their preferences for SM features (i.e., anonymity and similar-peer communities). Participants: Participants were 662 undergraduates (438 women) from two midwestern colleges who completed an online survey in Spring 2017. Methods: Students completed a demographic survey and depression/anxiety screener. They also indicated whether they turned to different people and SM resources when in distress. Results: Those with high depression were less likely to identify parents and mental health professionals as sources of support. Those with high depression/anxiety were more likely to identify SM as a social support medium and indicate preferences for similar-peer communities; however, they also identified SM as stress-inducing. Conclusions: SM may be a non-redundant source of social support for undergraduates. However, SM may be stress inducing. SM featuring anonymity and similar-peer communities might be appealing to students, especially those at-risk

    Tech-obsessed teens are still human: How do teens want to communicate during times of stress?

    No full text
    This discussion will focus on the findings from the Parkview Research Center\u27s Informatics team study, sponsored by the Robert Wood Johnson Foundation. In this three-phase study, we focused on who youth and young adults want to communicate with in times of stress and how they want this communication to occur. We used multiple study design methods (Delphi study, focus groups, surveys/polling technology) to gain a deeper understanding of the wants and needs of youth/young adults regarding their mental health, with the goal to help create, introduce and facilitate resources for coping strategies during times of stress

    Impact of Sepsis Order Set Updates on Carbapenem Utilization in a Community Regional Medical Center

    No full text
    2018 ASHP Midyear Clinical Meeting / Anaheim, California / Poster # ADD Background: Patients with penicillin allergies who require broad-spectrum antimicrobial therapy for the treatment of sepsis often receive a carbapenem instead of a cephalosporin due to concerns of penicillin-cephalosporin cross-reactivity. • As rates of antibiotic resistance continue to increase, institutions should prioritize efforts to preserve the efficacy of carbapenems. • Reduction of carbapenem use in institutions has been shown to lower incidence rates of carbapenem-resistant organisms . • Cephalosporins have previously demonstrated low rates of cross-reactivity in penicillin allergic patients. • As of May 29th, 2018, updates to our institution’s sepsis order sets recommend the use of cefepime in place of piperacillin/tazobactam in patients with a non-severe penicillin allergy rather than a carbapenem. • An analysis of the results of these updates is warranted to identify areas of improvement that can further reduce carbapenem utilization

    Implementation of non-opioid order panels in Parkview Health emergency departments

    Get PDF
    Presentation given at Great Lakes Pharmacy Residency Conference 201

    Addition of midodrine in ICU patients and the impact on vasopressor tapering

    Get PDF
    Presentation given at Great Lakes Pharmacy Residency Conference 201

    Using cardiac implantable electronic device data to facilitate health decision making: A design study

    No full text
    For some individuals who live with chronic heart failure (CHF), cardiac implantable electronic devices (CIEDs) offer lifesaving therapy. Remote monitoring data from CIEDs are transmitted on a routine schedule for highly trained clinical staff to review. However, the remote monitoring data and clinical interpretations are not directly accessible to patients. Hence, people living with CIEDs are not able to reflect on their health data, let alone take any health action based on relevant data buried in their electronic health record (EHR). Prior research has shown that properly timed and tailored health data through a personal health record (PHR) can enable individual decisions about health in novel ways. However, in order to be effective, patients’ needs must be well described before designing a tailored intervention. This study is an early investigation into ways in which complex CIED data can be harnessed to guide the health decisions of individuals living with CHF. To understand these information needs, we conducted four focus groups (N = 24) comprised of adults living with CHF (who were undergoing remote monitoring of their CIED data) and their informal caregivers (spouse or adult child). Focus group participants shared preferences for on-demand and personalized push message education. Through our analysis, we identified specific elements of device data and delivery design that can help promote reflection on changes in disease progression and CIED function over time. In this paper, we describe design ideas for the delivery of tailored CIED data and education that supports patient-level decision making Highlights • Patients wanted the device data that supported reflection on changes over time.• Patients preferred to receive data within a normal range on-demand.• Patients preferred to be notified immediately if data is within abnormal range.• Patients preferred to have access to educational information at any time on-demand

    14th Annual Parkview Research Symposium

    Get PDF
    14th Annual Parkview Research Symposium: Innovative Interventions in Healthcare Objectives * Discuss latest innovative interventions in informatics, oncology, cardiology, orthopedids and neurosurgery. * Develop a strategy for efficient diagnosis and treatment planning using the latest innovative techniques and research findings in informatics, oncology, cardiology, orthopedics and neurosurgery

    Use of Advanced Innovative Technologies to Manage Structural Heart Disease

    No full text

    Reaching Youth Where They Are

    No full text
    This brief discussion will focus on the mental, behavioral and emotional health resource, LookUpIndiana.org. LookUpIndiana is a website with three main objectives: 1. To provide educational resources in the area of mental and behavioral health. 2. To improve connectivity between consumers and mental health providers. 3. To assist in reducing the negative stigma associated with mental illness and addiction

    Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review.

    No full text
    Anticoagulation with unfractionated heparin during extracorporeal membrane oxygenation (ECMO) is common, but alternative agents are being evaluated for safety and efficacy. The objective of this analysis was to assess if a comprehensive bivalirudin dosing and monitoring protocol effectively guides dose adjustments and monitoring of bivalirudin in patients during ECMO. Our analysis included 11 patients who received bivalirudin during ECMO therapy and had dosing managed using our hospital derived protocol. Patients treated over a 1-year period were included in this retrospective analysis. Clinical characteristics and changes in activated partial thromboplastin time (aPTT) were evaluated from medical records to determine the efficacy of the dosing protocol. ECMO was initiated for acute respiratory distress syndrome in eight (72.7%) patients and for cardiac arrest in three (27.3%) patients. A total of 178 protocol guided dose adjustments were made during the study. Among the dose adjustments, 56 (31.5%) attained the protocol predicted aPTT level change, 96 (53.9%) of the measured aPTT changes were less than predicted, and 26 (14.6%) of the measured aPTT changes were more than predicted. On average, patients were within their defined therapeutic aPTT target range 66.3% of the time. All patients reached their designated aPTT target range within the first 24 hours of therapy. Significant bleeding was documented in eight (72.7%) patients. No clinically evident thromboembolic events were identified in vivo while cannulated. This analysis suggests that bivalirudin can be managed using a dosing protocol to provide anticoagulation therapy to patients during ECMO and can provide foundational guidance for dose adjustment and monitoring for other institutions

    305

    full texts

    774

    metadata records
    Updated in last 30 days.
    Parkview Health Research Repository
    Access Repository Dashboard
    Do you manage Open Research Online? Become a CORE Member to access insider analytics, issue reports and manage access to outputs from your repository in the CORE Repository Dashboard! 👇